Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP)-2, Recombinant Human Bone Morphogenetic Protein (rhBMP)-7), By Applications (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-Maxillofacial, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format: | Report Code: SR4654DR | Pages: 110

Market Segmentation

  1. Bone Morphogenetic Protein Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
    2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
  2. Bone Morphogenetic Protein Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Spinal Fusion
    2. Trauma
    3. Reconstructive Surgery
    4. Oral-Maxillofacial
    5. Others
  3. Regional Bone Morphogenetic Protein Market
    1. North America
      1. North America Bone Morphogenetic Protein Market By Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
      2. North America Bone Morphogenetic Protein Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Spinal Fusion
        2. Trauma
        3. Reconstructive Surgery
        4. Oral-Maxillofacial
        5. Others
      3. U.S.
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      4. Canada
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
    2. Europe
      1. Europe Bone Morphogenetic Protein Market By Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
      2. Europe Bone Morphogenetic Protein Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Spinal Fusion
        2. Trauma
        3. Reconstructive Surgery
        4. Oral-Maxillofacial
        5. Others
      3. U.K.
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      4. Germany
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      5. France
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      6. Spain
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      7. Italy
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      8. Russia
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      9. Nordic
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      10. Benelux
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      11. Rest of Europe
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
    3. APAC
      1. APAC Bone Morphogenetic Protein Market By Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
      2. APAC Bone Morphogenetic Protein Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Spinal Fusion
        2. Trauma
        3. Reconstructive Surgery
        4. Oral-Maxillofacial
        5. Others
      3. China
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      4. Korea
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      5. Japan
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      6. India
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      7. Australia
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      8. Taiwan
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      9. South East Asia
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      10. Rest of Asia-Pacific
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
    4. Middle East and Africa
      1. Middle East and Africa Bone Morphogenetic Protein Market By Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
      2. Middle East and Africa Bone Morphogenetic Protein Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Spinal Fusion
        2. Trauma
        3. Reconstructive Surgery
        4. Oral-Maxillofacial
        5. Others
      3. UAE
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      4. Turkey
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      5. Saudi Arabia
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      6. South Africa
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      7. Egypt
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      8. Nigeria
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      9. Rest of MEA
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
    5. LATAM
      1. LATAM Bone Morphogenetic Protein Market By Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
      2. LATAM Bone Morphogenetic Protein Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Spinal Fusion
        2. Trauma
        3. Reconstructive Surgery
        4. Oral-Maxillofacial
        5. Others
      3. Brazil
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      4. Mexico
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      5. Argentina
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      6. Chile
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      7. Colombia
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
      8. Rest of LATAM
        1. Recombinant Human Bone Morphogenetic Protein (rhBMP)-2
        2. Recombinant Human Bone Morphogenetic Protein (rhBMP)-7
        3. Spinal Fusion
        4. Trauma
        5. Reconstructive Surgery
        6. Oral-Maxillofacial
        7. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: